that they are comprehensive measures that look at multiple areas of health-related functioning in daily life. 12 The current study seeks to examine which aspects of low back-specific disability, as measured by the ODI, make the greatest impact in improving overall health-related quality of life, as measured by the SF-36, in patients undergoing lumbar spinal fusion.
Methods
The current study is a retrospective analysis of a clinical database of prospectively collected health outcomes data in patients undergoing lumbar fusion. A single-center surgical database of patients undergoing lumbar fusion surgery at a tertiary spine care center was reviewed from 2001 to the present. All patients undergoing lumbar decompression and instrumented fusion who had complete preoperative and 2-year postoperative outcomes data were included. Inclusion criteria were single-or multilevel lumbar decompression and fusion for standard lumbar degenerative disease as classified by Glassman et al., 7 including primary disc pathology, spondylolisthesis, instability, spinal stenosis, and short-segment fusion for lumbar scoliosis. All patients had axial or referred pain with or without associated radiculopathy or neurogenic claudication. Patients undergoing fusion for all other indications, including tumor, spinal infection, or significant spinal deformity (coronal curvature ≥ 30°, or sagittal or coronal imbalance) were excluded. The study protocol was approved by the Institutional Review Board.
All outcomes data were collected prospectively. Standardized questionnaires were administered prior to surgery and at 1 and 2 years postsurgery. Patients were asked to rate low-back pain and leg pain independently on a 10-point numeric rating scale (back pain and leg pain numeric rating scales), ranging from 0 (no pain) to 10 (worst possible pain). 9, 11 The questionnaires included the ODI as a measure of low back-specific disability 4 and the Medical Outcomes Study SF-36 PCS as a measure of general health-related quality of life. 13 Changes in outcome measures were evaluated based on mean changes from preoperative values to 2-year postoperative values. Patients were graded as to whether they reached the MCID for SF-36 PCS, using a 4.9-point improvement as a threshold. 3 Statistical analysis was performed using SPSS software (version 19.0, IBM SPSS, Inc.). Baseline and 2-year postoperative scores were compared using the Wilcoxon test. Pearson product moment correlation was used to evaluate associations between the 2-year change in each item of the ODI and the 8 SF-36 individual domains. Pearson correlation was also used to examine the relationship between changes in each question of the ODI with the change in SF-36 PCS score and with achieving SF-36 PCS MCID. Multivariate regression modeling with stepwise addition of variables was used to examine which questions of the ODI best predicted achievement of the MCID for SF-36 PCS. A subanalysis looking at the relationship between changes in each question of the ODI with the change in SF-36 PCS score stratified by the etiology of the patient's symptoms (spondylolisthesis, degenerative scoliosis, disc pathology, or stenosis) was also performed.
Discriminative properties of the 10 dimensions of the ODI were evaluated by computing the effect size 2, 8, 10 and the standardized response mean. The effect size is the difference in the mean change in scores from preoperative to postoperative divided by the standard deviation of the preoperative scores. The standardized response mean is the difference in the mean change in scores from preoperative to postoperative divided by the standard deviation of the change in scores from preoperative to postoperative. Cohen's definition for interpreting effect size was used.
2 Effect sizes and standardized response means greater than or equal to 0.8 were considered large, 0.5 as moderate, and 0.2 as small. The larger the effect size and standardized response mean, the more sensitive the measure is to change.
Results
A total of 1104 patients were included in the study; there were 674 female and 430 male patients. The mean age at surgery was 56.65 ± 12.7 years. There were 220 smokers (19.9%). The mean body mass index was 30.35 kg/m 2 . The summary of the descriptive statistics for the ODI and SF-36 scores are presented in Table 1 . Baseline and 2-year postoperative scores were statistically significantly different for all the measures and the individual ODI items. Although associations between the 2-year change in individual ODI items and the change in SF-36 domains were all statistically significant (p < 0.0001), only moderate correlations were seen between ODI sex life and SF-36 bodily pain (r = 0.485), role-physical (r = 0.534), social functioning (r = 0.491), and physical func- tioning (r = 0.513); and ODI standing (r = 0.456) and ODI walking (r = 0.499) and SF-36 physical functioning. Moderate correlations were also seen between the change in total ODI scores and change in SF-36 bodily pain (r = 0.522), physical functioning (r = 0.556), role-physical (r = 0.533), and social functioning (r = 0.469) ( Table 2) .
Pearson correlations between the individual ODI items with the change in SF-36 PCS score and with achieving SF-36 PCS MCID were all statistically significant (Table 3) . However, only the ODI dimensions of pain intensity, walking, and social life had r values reflecting moderate degrees of correlation. This is borne out by the stepwise regression analysis that these are the dimensions predictive of the change in SF-36 PCS score or achievement of the SF-36 PCS MCID. These same dimensions had effect sizes and standardized response means that can be interpreted as moderate to large ( Table 4) .
The subanalysis looking at the relationship between changes in each question of the ODI with the change in SF-36 PCS score stratified by the etiology of the patient's symptoms showed similar findings as the entire cohortthe difference being low degrees of correlation between the SF-36 PCS and pain intensity in patients with stenosis, low correlations between SF-36 PCS and walking in patients with degenerative scoliosis, and moderate correlations in SF-36 and standing in patients with spondylolisthesis and stenosis (Table 5 ).
Discussion
The current study examined which aspects of the ODI best predict improvement in overall health-related quality of life in patients undergoing lumbar fusion. Only moderate degrees of correlation were seen with specific items of the ODI, the ODI total scores, and specific domains of the SF-36. The lack of substantial correlation between the ODI items and SF-36 domains may indicate that these health-related quality of life surveys measure a different construct or latent variable and thus are not duplicative. Some degree of correlation was found between each of the specific dimensions of the ODI, and both change in SF-36 PCS score and the achievement of MCID for SF-36 PCS. Multivariate regression modeling showed that changes in pain, ability to walk, and social life were the most important predictors of improvement The use of disease-specific health status measures, such as the ODI, and generic quality of life measures, such as the SF-36, involve tradeoffs. Each has advantages and limitations. Disease-specific measures are designed to measure the health domains most salient to a particular disease process or patient population. For this reason, disease-specific measures tend to be more sensitive to treatment effects, as generic measures include assessment of health domains that may not be substantially affected by the disease process or by therapies used to treat it. Generic measures cast a wide net over a variety of health domains to give a global assessment of health-related quality of life. As such, they can be used to compare the effects of health interventions across different demographic subgroups and patient populations. Generic measures are a common language or currency that can be used by researchers in different areas of health care to facilitate comparisons of the usefulness of different medical therapies. The results of our study show that the ODI and the SF-36 measure different constructs or different aspects of health-related quality of life. By asking which aspects of the ODI are most important in determining meaningful changes in the SF-36 PCS scores, in essence we are asking which aspects of back pain are most critical to address to improve a given patient's overall quality of life.
The results of multivariate analysis in our study suggest that pain, walking, and social life are the areas of the ODI that most strongly explain overall health-related quality of life. Pain tends to be the predominant symptom reported when patients seek spine care; thus, it makes sense that diminution of pain would correlate most closely with overall quality of life. Walking and social life are somewhat less intuitive; however, both are aspects of health that are assessed directly with independent questions on the SF-36 survey; thus, a stronger correlation might be expected. Walking is also a necessary prerequisite for performing well in other areas of the SF-36, such as the ability to work and climb stairs. This "spillover effect" would again cause increased correlation with several domains of the SF-36. In contrast, several other components of the ODI, such as sitting, sleeping, sex life, and traveling, do not have direct assessment with dedicated items on the SF-36 and thus might be expected to have a lower correlation.
In the subanalysis, the correlations that were not consistent with the entire cohort can be attributed to the characteristics of the pathology. Thus, pain intensity on the ODI did not have an association with the SF-36 PCS score in patients with stenosis in whom the main symptom is neurogenic claudication. Standing was associated with the SF-36 PCS score in patients with spondylolisthesis, which may be reflective of the dynamic nature of the instability, and stenosis with increasing symptoms as the spine is in extension.
Limitations of our study include that its interpretation should be limited to the population who underwent lumbar fusion. Patients with predominant claudication or radiculopathy without low-back pain who typically undergo decompression alone may have very different areas of focus with respect to needs and expectations of treatment. Also, the study used the PCS score of the SF-36, which is not a true surrogate of overall health-related quality of life as it de-emphasizes domains pertaining to mental health, which is an important element of overall quality of life.
Conclusions
This study demonstrates that with clinical improvement after lumbar fusion, the components of the ODI tend to correlate with each other, and that pain, walking ability, and social life have the strongest correlation with overall health-related quality of life. The 2 instruments, the ODI and SF-36, provide the clinician with complementary information regarding the effect of treatment on a patient's quality of life. Again, a disease-specific instrument such as the ODI will include more targeted domains to the population with low-back pain than a generic measure such as the SF-36. An improved understanding of which domains of the ODI are most important in determining overall quality of life will help researchers interpret changes in ODI and help facilitate the use of the SF-36 in comparing treatments for low-back pain with other health care interventions.
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